サマリー

スペシャリティ医薬品の世界市場 2023-2027
スペシャリティ医薬品市場は2022〜2027年に3,311億2,000万米ドルの成長が予測され、予測期間中のCAGRは12.59%で加速すると予測されています。当レポートでは、スペシャリティ医薬品市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引しているのは、政府の医療費支出による研究開発需要の増加、特殊医薬品の探索・開発におけるコスト削減の必要性、複雑な疾患に対する認識を広めるための政府や各種非営利団体による取り組みなどです。
Technavioの特殊医薬品市場は以下のようにセグメント化されている：
用途別
- がん領域
- 多発性硬化症
- 炎症性疾患
- 感染症
- その他
販売チャネル別
- オフライン
- オンライン
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の特殊医薬品市場の成長を牽引する主な要因の1つとして、高齢者人口の増加を挙げている。また、メーカーによる特殊医薬品への研究開発投資の増加、バイオ医薬品業界における投資と開発の増加は、市場の大きな需要につながるでしょう。
本レポートでは、特殊医薬品市場について以下の分野をカバーしています：
- 特殊医薬品市場のサイジング
- 特殊医薬品市場の予測
- スペシャリティ医薬品市場の業界分析
本レポートでは、専門医薬品市場の主要ベンダーの詳細な分析を行っています、Biodexa Pharmaceuticals PLC、Bristol Myers Squibb Co.、Cigna Corp.、CVS Health Corp.、Endo International Plc、F. Hoffmann La Roche Ltd.、Gilead Sciences Inc.、Humana Inc.、Hyphens Pharma Pte Ltd.、Johnson and Johnson Services Inc.、Kroger Co.、McKesson Corp.、Merck and Co.Inc.、Novartis AG、Pfizer Inc.、Sanofi、Supernus Pharmaceuticals Inc.、Teva Pharmaceutical Industries Ltd.、UnitedHealth Group Inc.、Viatris Inc.また、特殊医薬品市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/specialty-pharmaceuticals-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global specialty pharmaceuticals market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global specialty pharmaceuticals market 2017 - 2021 ($ billion)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Oncology - Market size and forecast 2022-2027
o Exhibit 34: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
o 6.4 Multiple sclerosis - Market size and forecast 2022-2027
o Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
o 6.5 Inflammatory conditions - Market size and forecast 2022-2027
o Exhibit 42: Chart on Inflammatory conditions - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Inflammatory conditions - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Inflammatory conditions - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Inflammatory conditions - Year-over-year growth 2022-2027 (%)
o 6.6 Infectious diseases - Market size and forecast 2022-2027
o Exhibit 46: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ billion)
o Exhibit 55: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 56: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 57: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 58: Chart on Comparison by Distribution Channel
o Exhibit 59: Data Table on Comparison by Distribution Channel
o 7.3 Offline - Market size and forecast 2022-2027
o Exhibit 60: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 7.4 Online - Market size and forecast 2022-2027
o Exhibit 64: Chart on Online - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 68: Market opportunity by Distribution Channel ($ billion)
o Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 107: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 119: AbbVie Inc. - Overview
o Exhibit 120: AbbVie Inc. - Product / Service
o Exhibit 121: AbbVie Inc. - Key news
o Exhibit 122: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 123: Amgen Inc. - Overview
o Exhibit 124: Amgen Inc. - Product / Service
o Exhibit 125: Amgen Inc. - Key offerings
o 12.5 Biodexa Pharmaceuticals PLC
o Exhibit 126: Biodexa Pharmaceuticals PLC - Overview
o Exhibit 127: Biodexa Pharmaceuticals PLC - Product / Service
o Exhibit 128: Biodexa Pharmaceuticals PLC - Key offerings
o 12.6 Bristol Myers Squibb Co.
o Exhibit 129: Bristol Myers Squibb Co. - Overview
o Exhibit 130: Bristol Myers Squibb Co. - Product / Service
o Exhibit 131: Bristol Myers Squibb Co. - Key news
o Exhibit 132: Bristol Myers Squibb Co. - Key offerings
o 12.7 Cigna Corp.
o Exhibit 133: Cigna Corp. - Overview
o Exhibit 134: Cigna Corp. - Product / Service
o Exhibit 135: Cigna Corp. - Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 Gilead Sciences Inc.
o Exhibit 141: Gilead Sciences Inc. - Overview
o Exhibit 142: Gilead Sciences Inc. - Product / Service
o Exhibit 143: Gilead Sciences Inc. - Key news
o Exhibit 144: Gilead Sciences Inc. - Key offerings
o 12.10 Johnson and Johnson Services Inc.
o Exhibit 145: Johnson and Johnson Services Inc. - Overview
o Exhibit 146: Johnson and Johnson Services Inc. - Business segments
o Exhibit 147: Johnson and Johnson Services Inc. - Key news
o Exhibit 148: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 149: Johnson and Johnson Services Inc. - Segment focus
o 12.11 McKesson Corp.
o Exhibit 150: McKesson Corp. - Overview
o Exhibit 151: McKesson Corp. - Business segments
o Exhibit 152: McKesson Corp. - Key offerings
o Exhibit 153: McKesson Corp. - Segment focus
o 12.12 Merck and Co. Inc.
o Exhibit 154: Merck and Co. Inc. - Overview
o Exhibit 155: Merck and Co. Inc. - Business segments
o Exhibit 156: Merck and Co. Inc. - Key news
o Exhibit 157: Merck and Co. Inc. - Key offerings
o Exhibit 158: Merck and Co. Inc. - Segment focus
o 12.13 Novartis AG
o Exhibit 159: Novartis AG - Overview
o Exhibit 160: Novartis AG - Business segments
o Exhibit 161: Novartis AG - Key offerings
o Exhibit 162: Novartis AG - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 163: Pfizer Inc. - Overview
o Exhibit 164: Pfizer Inc. - Product / Service
o Exhibit 165: Pfizer Inc. - Key news
o Exhibit 166: Pfizer Inc. - Key offerings
o 12.15 Sanofi
o Exhibit 167: Sanofi - Overview
o Exhibit 168: Sanofi - Business segments
o Exhibit 169: Sanofi - Key news
o Exhibit 170: Sanofi - Key offerings
o Exhibit 171: Sanofi - Segment focus
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 172: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 173: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 176: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 177: Viatris Inc. - Overview
o Exhibit 178: Viatris Inc. - Business segments
o Exhibit 179: Viatris Inc. - Key news
o Exhibit 180: Viatris Inc. - Key offerings
o Exhibit 181: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 182: Inclusions checklist
o Exhibit 183: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 184: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 185: Research methodology
o Exhibit 186: Validation techniques employed for market sizing
o Exhibit 187: Information sources
o 13.5 List of abbreviations
o Exhibit 188: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global specialty pharmaceuticals market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Inflammatory conditions - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Inflammatory conditions - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Inflammatory conditions - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Inflammatory conditions - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ billion)
Exhibits55: Data Table on Market opportunity by Application ($ billion)
Exhibits56: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits57: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Distribution Channel
Exhibits59: Data Table on Comparison by Distribution Channel
Exhibits60: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Online - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Distribution Channel ($ billion)
Exhibits69: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. - Overview
Exhibits120: AbbVie Inc. - Product / Service
Exhibits121: AbbVie Inc. - Key news
Exhibits122: AbbVie Inc. - Key offerings
Exhibits123: Amgen Inc. - Overview
Exhibits124: Amgen Inc. - Product / Service
Exhibits125: Amgen Inc. - Key offerings
Exhibits126: Biodexa Pharmaceuticals PLC - Overview
Exhibits127: Biodexa Pharmaceuticals PLC - Product / Service
Exhibits128: Biodexa Pharmaceuticals PLC - Key offerings
Exhibits129: Bristol Myers Squibb Co. - Overview
Exhibits130: Bristol Myers Squibb Co. - Product / Service
Exhibits131: Bristol Myers Squibb Co. - Key news
Exhibits132: Bristol Myers Squibb Co. - Key offerings
Exhibits133: Cigna Corp. - Overview
Exhibits134: Cigna Corp. - Product / Service
Exhibits135: Cigna Corp. - Key offerings
Exhibits136: F. Hoffmann La Roche Ltd. - Overview
Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
Exhibits138: F. Hoffmann La Roche Ltd. - Key news
Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits141: Gilead Sciences Inc. - Overview
Exhibits142: Gilead Sciences Inc. - Product / Service
Exhibits143: Gilead Sciences Inc. - Key news
Exhibits144: Gilead Sciences Inc. - Key offerings
Exhibits145: Johnson and Johnson Services Inc. - Overview
Exhibits146: Johnson and Johnson Services Inc. - Business segments
Exhibits147: Johnson and Johnson Services Inc. - Key news
Exhibits148: Johnson and Johnson Services Inc. - Key offerings
Exhibits149: Johnson and Johnson Services Inc. - Segment focus
Exhibits150: McKesson Corp. - Overview
Exhibits151: McKesson Corp. - Business segments
Exhibits152: McKesson Corp. - Key offerings
Exhibits153: McKesson Corp. - Segment focus
Exhibits154: Merck and Co. Inc. - Overview
Exhibits155: Merck and Co. Inc. - Business segments
Exhibits156: Merck and Co. Inc. - Key news
Exhibits157: Merck and Co. Inc. - Key offerings
Exhibits158: Merck and Co. Inc. - Segment focus
Exhibits159: Novartis AG - Overview
Exhibits160: Novartis AG - Business segments
Exhibits161: Novartis AG - Key offerings
Exhibits162: Novartis AG - Segment focus
Exhibits163: Pfizer Inc. - Overview
Exhibits164: Pfizer Inc. - Product / Service
Exhibits165: Pfizer Inc. - Key news
Exhibits166: Pfizer Inc. - Key offerings
Exhibits167: Sanofi - Overview
Exhibits168: Sanofi - Business segments
Exhibits169: Sanofi - Key news
Exhibits170: Sanofi - Key offerings
Exhibits171: Sanofi - Segment focus
Exhibits172: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits173: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits174: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits175: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits176: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits177: Viatris Inc. - Overview
Exhibits178: Viatris Inc. - Business segments
Exhibits179: Viatris Inc. - Key news
Exhibits180: Viatris Inc. - Key offerings
Exhibits181: Viatris Inc. - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations